目的 采用尤斯室(Ussing Chamber)技术考察黄连水煎液中微粒体系对小檗碱(berberine,Ber)离体肠黏膜透过特性的影响及相关机制研究。方法 常规煎煮黄连,高速离心得黄连水煎液中的微粒体系;采用尤斯室技术,考察Ber在大鼠不同肠段的吸收情况以及黄连水煎液中微粒体系对Ber肠黏膜透过的影响;采用Western blot检测肠黏膜中紧密连接相关蛋白ZO-1、Occludin、claudin-1的蛋白表达水平。结果 Ber在大鼠小肠全肠段均有吸收,空肠吸收最好;黄连水煎液中的微粒体系显著促进Ber的吸收;微粒体系可显著下调小肠上皮细胞紧密连接相关蛋白ZO-1与Occludin的表达水平,且与加入微粒体系的剂量呈正相关。结论 基于尤斯室技术建立动物离体实验模型,黄连水煎液中微粒体系能显著增加Ber的肠黏膜透过性,这可能与其下调紧密连接蛋白表达有关。
Abstract
OBJECTIVE To investigate the effect and mechanism of particle aggregates in Coptis chinensis decoction on the permeability of berberine(Ber) through isolated intestinal mucosa based on Ussing chamber technique. METHODS Coptis chinensis decoction was prepared by conventional decocting method, and the particle aggregates of Coptis chinensis decoction were obtained by high-speed centrifugation. The absorption of Ber in different intestinal segments of rats and the effect of particle aggregates in Coptis chinensis decoction on the permeability of Ber intestinal mucosa were studied by Ussing chamber technique. The protein expression levels of ZO-1, occludin and claudin-1 in intestinal mucosa were detected by Western blot. RESULTS Ber was absorbed in the whole intestinal segment of rats, and the jejunum was the best. Particle aggregates in Coptis chinensis decoction significantly promoted the absorption of Ber. Particle aggregates could significantly down-regulate the expression level of ZO-1 and occludin, which was positively correlated with the dosage of solid particles. CONCLUSION The animal model in vitro was established by Ussing chamber technique, the particle aggregates in Coptis chinensis decoction can significantly increase the intestinal permeability of Ber, which may be related to the down-regulation of the expression of tight junction protein.
关键词
尤斯室 /
小檗碱 /
微粒体系 /
黄连水煎液 /
紧密连接
{{custom_keyword}} /
Key words
Ussing chamber /
berberine /
particle aggregates /
Coptis chinensis decoction /
tight junction
{{custom_keyword}} /
中图分类号：
R945
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] MA Y G, YUAN L, WANG W Q, et al. Study on intestinal absorption features of berberine hydrochloride phospholipid solid dispersions by rat single-pass perfusion model[J]. Chin Tradit Herb Drugs(中草药), 2017, 9(48):1820-1825.
[2] HAN C Y, SUN T T, XV G P, et al. Berberine ameliorates CCl4 induced liver injury in rats through regulation of the Nrf2Keap1ARE and p53 signaling pathways[J]. Mol Med Rep, 2019, 20(4):3095-3102.
[3] LI G F, ZHAO M M, SU X Y, et al. Preparation and in vitro-in vivo evaluation of intestinal retention pellets of berberine chloride to enhance hypoglycemic and lipid-lowing efficacy[J]. Asian J Pharm Sci, 2019, 14(5):559-568.
[4] YUAN X Y, XU H H, SHAO F P, et al. Influences of chitosan nanoparticles on the berberine transport through Caco-2 cell monolayer[J]. Chin J New Drugs(中国新药杂志), 2018, 27(6):708-713.
[5] WEI L, ZHU M L, DONG Y L, et al. Study on property of biopharmaceutics classification system of berberine in Huanglian decoction[J]. China J Chin Mater Med(中国中药杂志), 2016, 41(7):1192-1197.
[6] JIAO F, HOU Z Y, YIN D K, et al. Effect of solid particles in Coptis decoction on intestinal absorption of berberine in situ[J]. Chin Tradit Herb Drugs(中草药), 2016, 47(8):1357-1360.
[7] LIN J C, WU J Q, WANG F, et al. Qingbai decoction regulates intestinal permeability of dextran sulphate sodium-induced colitis through the modulation of notch and NF-κB signalling[J]. Cell Prolifer, 2019, 52(2):e12547.
[8] LUO L, ZHOU Z, XUE J, et al. Bletilla striata polysaccharide has a protective effect on intestinal epithelial barrier disruption in TAAinduced cirrhotic rats[J]. Exp Thera Med Tradit, 2018, 16(3):1715-1722.
[9] TIAN S Y, GUO R X, WEI S C, et al. Curcumin protects against the intestinal ischemia-reperfusion injury: involvement of the tight junction protein ZO-1 and TNF-α related mechanism[J]. Korean J Physiol Pharmacol, 2016, 20(2):147-152.
[10] HUANG J, GUO L, TAN R, et al. Interactions between emodin and efflux transporters on rat enterocyte by a validated ussing chamber technique[J]. Front Pharmacol, 2018, 9:646.
[11] GUO N, HU Z W, FAN X X, et al. Simultaneous determination of salidroside and its aglycone metabolite p-Tyrosol in rat plasma by liquid chromatography-tandem mass spectrometry[J]. Molecules, 2012, 17(4):4733-4754.
[12] GU X, YAO S Z, PI J X, et al. Study on permeabilities of salidroside via rat mesentery mucosa by using Ussing Chamber[J]. Tianjin Tradit Chin Med (天津中医药), 2016, 33(11):689-693.
[13] XU H H, YANG Y, CHEN Q Q, et al. Effect of Coptis chinensis water decoction microparticle system on tight junction structure and expression of tight junction protein ZO-1 in intestinal epithelial cells of rats[J]. J Anhui Tradit Chin Med Coll(安徽中医药大学学报), 2018, 37(6):64-68.
[14] ZHU Y, GU X, ZHANG B, et al. Rat intestinal absorption study of Zexie decoction with Ussing chamber by UPLC-MS/MS[J]. J Tianjin Univ Tradit Chin Med(天津中医药大学学报), 2017, 36(4):299-302.
[15] UNGELL A L, NYLANDERS U, GONSCHIOR A K, et al. Membrane transport of drugs in different regions of the intestinal tract of the rat[J]. J Pharm Sci, 1998, 87(3):360-366.
[16] LANE L L. A guide to Ussing chamber studies of mouse intestine[J]. Am J Physiol Gastrointest Liver Physiol, 2009, 296(6):1151-1166.
[17] LI M, SI L Q, PAN H P, et al. Excipients enhance intestinal absorption of ganciclovir by P-gp inhibition: assessed in vitro by everted gut sac and in situ by improved intestinal perfusion[J]. Int J Pharm, 2011, 403(1-2):37-45.
[18] SHEN Y, XU B L, YANG X Y, et al. Three methods for mechanism of drug intestinal absorption[J]. J Harbin Univ Comm(Nat Ed)(哈尔滨商业大学学报:自然科学版), 2016, 32(1):11-13.
[19] WATANABE E, TAKAHASHI M, HAYASHI M. A possibility to predict the absorbability of poorly water-soluble drugs in humans based on rat intestinal permeability assessed by an in vitro chamber method[J]. Eur J Pharm Biopharm, 2004, 58(3):659-665.
[20] WANG X Q, LIU Y L, LIN L F, et al. Development, measurement, and application of biopharmaceutics classification system for Chinese materia medica[J]. Chin Tradit Herb Drugs(中草药), 2018, 49(12):2742-2748.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
基金
国家自然科学基金项目资助(81874348,81303239);安徽省自然科学基金项目资助(1908085J29);安徽省重点研究与开发计划(对外科技合作)专项资助(201904b11020023)
{{custom_fund}}
PDF(1551 KB)
